The Hindu·3 min read·medium
Thai FDA approves new treatment for gonorrhoea
T
The Hindu Bureau
✦AI Summary
Thailand's FDA has approved Nuzolvence (zoliflodacin), a new oral antibiotic designed to treat uncomplicated urogenital gonorrhoea. Developed through a partnership between GARDP, Dr. Reddy’s Laboratories, and Innoviva, the drug offers a critical new option for addressing multidrug-resistant strains.
Thailand’s Food and Drug Administration has approved Nuzolvence (zoliflodacin), a first-in-class oral antibiotic for the treatment of uncomplicated urogenital gonorrhoea for which Dr. Reddy’s Laboratories with support from The GARDP Foundation had led the priority review submission.
healthsciencebusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in